Abstract

The Enrichment Program is directed by Atul Bhan. In this role, Dr. Bhan will review and make recommendations for the proposed speakers and topics of the GI Seminar series, Immunology Seminar series, IBD Research Club meetings, the annual Symposium and Workshop, and the annual Current Techniques in Molecular Genetics course. He will ensure that the goals of the Enrichment Program are met, in conjunction with an oversight committee comprised of Dr. Bhan (Chair), Ramnik Xavier, Hans-Christian Reinecker, Cornelis Terhorst, and Mark Daly. In aggregate, the activities of the Enrichment Program help provide the CSIBD with both institutional and extramural identity. The Enrichment Program fortifies the Center?s research environment by introducing new information and new scientific approaches to New England-area research teams and providing an outlet for communication of advancements with the larger CSIBD and Boston-area scientific communities. The programs enhance a scientific milieu by providing constructive feedback to Center investigators and motivate and support young investigators to pursue digestive diseases research.
The specific aims of the Enrichment Program are to (1) provide a comprehensive program of education and training to members of the CSIBD; (2) ensure that investigators are aware of the latest research relevant to the overall scientific mission of the Center; and (3) foster collaboration and interaction among CSIBD investigators.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK043351-28
Application #
9399653
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
28
Fiscal Year
2018
Total Cost
Indirect Cost

  Institution

Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code

  Publications

Schirmer, Melanie; Franzosa, Eric A; Lloyd-Price, Jason et al. (2018) Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol 3:337-346
Luther, Jay; Gala, Manish; Patel, Suraj J et al. (2018) Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways. Dig Dis Sci 63:738-745
Graham, Daniel B; Luo, Chengwei; O'Connell, Daniel J et al. (2018) Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nat Med 24:1762-1772
Chang, Yu-Ling; Rossetti, Maura; Vlamakis, Hera et al. (2018) A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol :
Cheung, Pui W; Terlouw, Abby; Janssen, Sam Antoon et al. (2018) Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation. J Physiol :
Kolde, Raivo; Franzosa, Eric A; Rahnavard, Gholamali et al. (2018) Host genetic variation and its microbiome interactions within the Human Microbiome Project. Genome Med 10:6
Khalaf, Natalia; Yuan, Chen; Hamada, Tsuyoshi et al. (2018) Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. Gastroenterology 154:1380-1390.e5
Angelini, Alessandro; Miyabe, Yoshishige; Newsted, Daniel et al. (2018) Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis. Nat Commun 9:1461
Franzosa, Eric A; McIver, Lauren J; Rahnavard, Gholamali et al. (2018) Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods 15:962-968
Mashayekhi, Rouzbeh; Bellavance, Danielle R; Chin, Samantha M et al. (2018) Obesity, but Not Physical Activity, Is Associated With Higher Prevalence of Asymptomatic Diverticulosis. Clin Gastroenterol Hepatol 16:586-587

Showing the most recent 10 out of 1166 publications